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Summary The present study was conducted to evaluate scopolamine-induced con-
vulsions in fasted mice after food intake effects on the cortical electroencephalogram
(EEG). Continuous EEG recordings were taken with Neuroscan for 10 min in freely
moving mice with six chronic cortical electrode implants. Animals were weighed and
deprived of food for 48 h. EEG recordings were taken at the 24th and 48th hour after
their food deprivations. Later, all animals were treated with saline or scopolamine of
3 mg/kg i.p. and EEG recordings were repeated for 10 min. Twenty minutes later, they
were given food pellets and were allowed to eat ad libitum. All animals were observed
for 60 min todetermine the incidence and onset of convulsions and EEG recordingswere
taken simultaneously. The present results demonstrate that food deprivation causes
differences in EEG in the elapsed time. The changes in EEG induced after food
deprivation become different with scopolamine administration. In scopolamine treat-
ment group, eating caused a series of high-voltage polyspikes and synchronized spikes
with a predominant frequency in the 1—3 Hz range and fast activity that represents a
typical epileptiform manifestation. It was concluded that the EEG properties and the
behavioral patterns of these convulsions are in accordance with each other.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
During the training sessions of the experiments inves-
tigating the effects of scopolamine on memory and
learning processes inmice, we observed that some of* Corresponding author. Tel.: +90 212 414 20 00x33355;
fax: +90 212 532 41 71.
E-mail address: nurtena@istanbul.edu.tr (A. Nurten).
1059-1311/$ — see front matter # 2006 British Epilepsy Association
doi:10.1016/j.seizure.2006.06.006the fasted animals exhibited seizures soon after find-
ing and starting to eat the food pellet in the maze.
Then, we described that mice treated with scopola-
mine after fasting for 48 h have developed clonic
convulsions soon after allowed to eat ad libitum.1—4
The additive effect of scopolamine treatment and
access to food is essential in the induction of convul-
sions.5 Interestingly, scopolamine reverses convul-
sions elicited by the anticholinesterase compound. Published by Elsevier Ltd. All rights reserved.
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carpine.8 It is suggested that scopolamine, as a mus-
carinic antagonist, blocks postsynaptic muscarinic
receptors and produces its anticonvulsive activity
via reducing cholinergic transmission. On the other
hand, it is shown that the topical administration of
scopolamine to the cerebral cortex in high concen-
trations induces the convulsive activity in electrocor-
ticogram.9 It is well documented that scopolamine,
acting at the presynapticmuscarinic receptors on the
cholinergic synapses, also enhances acetylcholine
release.10,11 Thereby, cholinergic hyperactivity due
to increased transmission at the cholinergic synapses
may lead to convulsions in scopolamine pretreated
fasted animals. Also, scopolamine-induced glutama-
tergic hyperactivity may cause these convulsions,
since scopolaminemay enhance glutamatergic trans-
mission via antagonizing the presynaptic cholinergic
inhibition on glutamate release.12,13 Changes in [3H]
glutamate binding induced by fasting and reversal by
scopolamine treatment and food intake have been
evaluated as glutamatergic contributions to the
underlying mechanism(s) of these convulsions.3 Pre-
vious findings also showed that noncompetitive N-
methyl-D-aspartate (NMDA) antagonist MK-801,1
alpha-2 agonists clonidine and tizanidine2 and dopa-
minergic antagonists chlorpromazine and haloperi-
dol3 suppressed these convulsions.
The effects of anticonvulsant drugs on convul-
sions are also evaluated and it is found that convul-
sions do not respond to most of the conventional
anticonvulsant drugs except valproat, gabapentin
and diazepam that markedly reduce the incidence
of scopolamine-induced convulsions.4
Hypoglycaemia is one of the metabolic derange-
ments that cause convulsions.14 Previous findings
showed that a moderate degree of hypoglycaemia
occurs in fasted mice after 48 h of food deprivation
and plasma glucose levels increase to fed levels
after refeeding for 5—10 min.3,15,16 Although food
intake increases plasma glucose levels immediately
near to fed levels in 5 min, plasma glucose concen-
trations sustain at the same levels after refeeding in
scopolamine treated animals. However, hypoglycae-
mia present in saline or scopolamine treated ani-
mals does not cause convulsions in those animals.3 It
was shown in the previous experiments that, while
the plasma glucose is at normoglycaemic level, a
decrease in the cerebral glucose level could cause
convulsions. In glucose transporter type1 (GLUT-1)
deficiency17 where the plasma glucose is at normo-
glycaemic level while cerebrospinal fluid glucose is
at low levels, seizure frequency and intensity
increase after fasting for a few hours, predomi-
nantly in the morning, before breakfast and rapidly
improve after intake of sweets.18The electroencephalographic patterns during
scopolamine-induced convulsions in fasted mice
after food intake were not described yet. In view
of the facts mentioned above, the present study was
conducted to evaluate scopolamine-induced convul-
sions in fasted mice after food intake effects on the
cortical electroencephalogram.Materials and methods
Animals
Inbred albino Balb/C male mice weighing 25—30 g
were used. They were housed under standard
laboratory conditions for at least 1 week prior to
experimentation and were allowed to free access to
both food and water. All animal studies carefully
conformed to the guidelines outlined in Interdisci-
plinary Principles and Guidelines for the Use of
Animals in Research and Education from the New
York Academy of Sciences.
Electrode implantation
Animals were anesthetized with thiopental (50 mg/
kg i.p.) and positioned in a stereotaxic apparatus.
The EEG electrodes were constructed from insu-
lated stainless steel wire (200 mm diameter) with
insulation removed at the end to form the contact.
Six holes were drilled through the skull, and elec-
trodes were positioned to contact the dura of the
frontal, parietal and occipital regions of the cere-
brum. A reference electrode was placed above the
cerebellum. Electrodes were fixed on the skull with
dental acrylic cement. Third-generation cephalos-
porins seftriakson (75 mg/kg, i.m.) was given single
dose as an antibiotic agent after the surgery.
Recording of EEG
Eight days after operation, the experiment was
performed in freely moving mice that lived in a
Plexiglas recording cage. Animals were placed with
their recording cage in a Faraday cage and contin-
uous EEG recordings were taken for 10 min with
Neuroscan (SynAmps Model 5083, USA). The beha-
vior of the animals during the EEG recording session
was observed. For each animal, a control EEG sam-
ple was recorded before the experiment began and
was used as a baseline value to compare all subse-
quent EEG recordings for that animal.
EEG signals were recorded with a band pass of
0.30—70 Hz digitally with a sampling frequency of
1000 Hz. After giving foods, EEG was recorded for
60 min, properties of EEG were specified and power
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The frequency band of 0—3 Hz was expressed as
delta, 3.5—7 Hz as theta, 7.5—12 Hz as alpha,
12.5—20 Hz as beta, and 20.5—45 Hz as gamma.
Evaluation of effect of scopolamine
One week after the operation, continuous EEG
recording were taken with Neuroscan for 10 min in
freely moving mice. A group of animals (n = 6) was
given scopolamine 3 mg/kg i.p. and EEG recordings
were taken for 10 min.Another groupof animalswere
weighed anddeprived of food for 48 h andwere given
tap water (fasted). EEG recordings were taken at the
24th and 48th hour of their food deprivation periods.
Later all animals were treated with saline or scopo-
lamine 3 mg/kg i.p. and again EEG recordings were
taken for 10 min. Twenty minutes later, they were
given foodpellets, about 2 g, andwere allowed toeat
ad libitum. All animals were observed for 60 min to
determine the incidenceandonset of convulsions and
EEG recordings were taken simultaneously. Seizure
activity was quantified by staging; (1) freezing and
gustatory movements; (2) forelimb clonus; (3) fore-
limb clonus with rearing; (4) forelimb clonus with
rearing and falling down; (5) generalized convulsions
with rearing, falling down and jumping. A convulsive
response was assessed as forelimb clonus with rear-
ing. Onset of convulsions was defined as the time
passedbefore ananimal displays forelimbclonuswith
rearing after starting to eat. Incidence of convulsions
was expressed as the percentage of animals display-
ing forelimb clonus with rearing (either stage 3, 4 or
5) in each group.
Experiments were carried out between 9:00 and
14:00 in a temperature controlled (21  2 8C) quiet
room. Observers were blind to the treatments.Drugs
Scopolamine hydrobromide, thiopental and sef-
triakson were obtained from Sigma, St. Louis, MO
and Ibrahim Ethem Ulagay, respectively. Scopola-
mine and thiopental were dissolved in saline and
given i.p. in a volume of 4 ml/kg body weight.
Seftriakson was dissolved in 1% lidocain and given
i.m. in a volume of 2 ml/kg body weight.
Statistical analysis
Fisher’s Exact test (n < 20) was used to evaluate the
frequency of the incidence of convulsions. The onset
of convulsions was evaluated with Student’s t-test.
Continuous EEG recordings were divided into 2-s
epochs and epochs with movement artifacts (i.e.
exceeding 500 mV), were extracted automatically.
Then, epochs were analyzed by averaged frequency
spectra. The part from 0 to 48 Hz was normalized
(was equalized to 100). Moving averages were cal-
culated for five points. A repeated measures ANOVA
followed by a series of point to point two tail paired
Student’s t-test was applied for the each channel for
the values of basal and for the values that were
recorded at 24th and 48th hour of fasting and
scopolamine treatments. p < 0.05 was accepted
to be statistically significant.Results
The body weights of the mice fell approximately to
88—90 and 80—85% of the starting body weights
after fasting for 24 and 48 h, respectively.
Regarding the power spectral analysis, all groups
showed statistically significant difference with
512 A. Nurten et al.respect to each other groups (F(100,25) =2.273,
p < 0.01 by RM-ANOVA). The animals displayed nor-
mal EEG consisted of variable delta and theta activ-
ity. Amplitudes of delta activity differed per
monitored brain area, with the lowest amplitudes
in the parietal and the highest in the occipital area.
Amplitudes of theta activity differed per monitored
brain area, with the lowest amplitudes in the occi-
pital and the highest in the frontal area (Fig. 1).
Besides, spikes and sharp waves were observed
rarely in baseline EEG (Fig. 2). At the 24th hour
of fasting, the amplitudes of delta frequency
decreased significantly in almost all localizations
according to the baseline value. The peak point of
theta activity shifted from 4 to 6 Hz and the ampli-
tudes of theta activity increased significantly in
parietal, occipital and frontal localizations, respec-
tively. The amplitudes of beta increased only at the
left frontal electrode. The amplitudes of gamma
frequencies increased significantly in almost all
localizations at the 24th hour of fasting (Fig. 1).
Besides, spikes and sharp waves were increasedFigure 1 Moving averaged amplitude spectra of 24-h fasting
normal EEG consisted of variable delta and theta activity. In ba
brain area, with the lowest amplitudes in the parietal and th
activity differed per monitored brain area, with the lowest am
the 24-h of fasting, the amplitudes of delta frequency decreas
baseline value. The peak point of theta activity shifted from 4
occipital and frontal localizations, respectively. The amplitude
amplitudes of gamma frequencies increased significantly in aaccording to the baseline value (Fig. 2). At the
48th hour of fasting, the amplitudes of delta fre-
quency increased significantly in all localizations
while the amplitudes of theta frequency decreased
significantly in only frontal left localization and the
amplitudes of gamma frequency increased in only
parietal localizations according to the baseline
value (Fig. 3). At the 48th hour of fasting, the
amplitudes of delta frequency increased signifi-
cantly in all localizations while the amplitudes of
theta and alpha frequencies decreased significantly
in all localizations according to the 24th hour value
(Fig. 4). At the 48th hour of fasting, spikes and sharp
waves were observed intensively (Fig. 2).
In EEG of the animals that fasted for 48 h injected
with scopolamine, the amplitudes of delta and theta
frequencies decreased significantly in frontal and
parietal localizations and the amplitudes of alpha
and beta frequencies increased significantly in par-
ietal and occipital localizations according to 48th
hour value. The amplitude of gamma frequency
decreased significantly in all localizations (Fig. 5).values compared with basal values. The animals displayed
seline, amplitudes of delta activity differed per monitored
e highest in the occipital area while amplitudes of theta
plitudes in the occipital and the highest in the frontal. At
ed significantly in almost all localizations according to the
to 6 Hz and the amplitudes of theta increased in parietal,
s of beta increased only for the frontal left electrode. The
lmost all localizations at the 24-h of fasting.
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Figure 2 Effects of basal, 24th and 48th hour of fasting and scopolamine treatment on spikes and sharp waves in right
and left frontal, parietal and occipital electrodes, respectively (rF, lF, rP, lP, rO, lO). Spikes and sharp waves were
observed rarely in baseline EEG. In the 24th hour of fasting, spikes and sharp waves were increased according to the
baseline value. At the 48th hour of fasting, spikes and sharp waves were observed intensively. Scopolamine induced an
increase in the amplitudes of spikes and sharp waves according to the 48th hour value.Scopolamine induced an increase in the amplitudes
of spikes and sharp waves according to the 48th hour
value (Fig. 2). In scopolamine administrated ani-
mals’ EEG the amplitudes of theta and gamma
frequencies decreased significantly in all localiza-
tions and the amplitudes of alpha and beta frequen-
cies increased significantly in parietal localizations
according to basal value (Fig. 6).Table 1 shows that scopolamine treatment caused
convulsions in fasted animals and this effect was
statistically significant when compared to saline
treated control group (p < 0.02). One of 12 animals
was not included in the experiment, because he did
not eat during the experiment. Convulsion was not
observed in two animals of the remaining 11 animals
in the 60 min observation time. But stage 3 convul-
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Figure 3 Moving averaged amplitude spectra of 48-h fasting values compared with basal values. At the 48 h of fasting,
the amplitudes of delta frequency increased significantly in all localizations while the amplitudes of theta frequency
decreased significantly in only frontal left localization and the amplitudes of gamma frequency increased in only parietal
localizations according to the baseline value.sions were observed in these two animals after
60 min. One of the remaining animals had stage 2,
the other two had stage 3, the other two had stage 4
and the last four animals had stage 5 convulsions.
Three of the animals that had stage 5 convulsions
died due to the repeating tonic clonic generalized
convulsions. No EEG changes or behavioral epileptic
signs due to eating were observed in the control
animals. In scopolamine treatment group, changes
in EEG began few minutes after eating. Eating
caused initial EEG changes in the form of sporadic
isolated sharp waves. Early changes in the EEG were
characterized typically by low amplitude and high
frequency activity that rapidly degenerated into
high-amplitude polymorphic epileptiform spikes.
They progressed into a series of high-voltage poly-
spikes and synchronized spikes with a predominant
frequency in the 1—3 Hz range and fast activity that
represents a typical epileptiform manifestation.
During this, animals showed behavioral stage 2 con-
vulsions. Immediately after the seizure off set,
profound postictal depression and power spectradecrease was observed in EEG recordings. In stage
3, paroxystic high frequency spikes were obvious in
parietal localization. Stage 4 that began with the
appearance paroxysmal high frequency spikes was
obvious in all localizations. Stage 5 was character-
ized with paroxysmal high frequency spikes of flat
periods interrupting the seizure discharge and by
progressive lengthening of the flat periods which
eventually developed into a pattern that was pre-
dominantly flat punctuated by periodic high-voltage
sharp waves. The transition from stage 4 to 5
occurred when the duration of the flat periods
exceeded the duration of the sharp waves (Fig. 7).Discussion
The present results demonstrate that food depriva-
tion has induced differences in EEG in the observed
time. Notably, fasting increases synchronized activ-
ity in EEG. We found that a decrease in the ampli-
tude of delta frequency and an increase in the
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Figure 4 Moving averaged amplitude spectra of 48-h fasting values compared with 24-h values. At the 48 h of fasting,
the amplitudes of delta frequency increased significantly in all localizations while the amplitudes of theta and alpha
frequencies decreased significantly in all localizations according to the 24-h value.amplitudes of theta and gamma frequencies
occurred at the first 24-h period of fasting. At the
end of the 48 h period of fasting, amplitude of delta
frequency that was decreased at the end of the 24 h,
showed a statistically significant increase compared
to basal and 24 h fasting periods. Also at the end of
the 48 h period of fasting, in almost all localizations,
amplitudes of theta frequency that were increased
at the end of the 24 h, showed a statistically sig-
nificant decrease compared to 24 h fasting while a
significant decrease was observed in the amplitudes
of theta frequency according to the values of basal
only at left frontal localizations. In human, during
basal recordings with blood glucose levels of 50—
80 mg/dl, alpha rhythm slows and intermittent
theta activity appears. Those findings support our
results for 24 h fasting periods. When levels fall
below 40 mg/dl, diffuse theta and delta activity
appears interspersed with intermittent rhythmic
delta activity.19 Parallel to those findings in our
research, it is found that in 48 h fasted mice with
low plasma glucose levels, the amplitudes of delta
frequency increased significantly in all localizations
while the amplitudes of theta and alpha frequencies
decreased significantly in all localizations accordingto the 24th hour value. In humans EEG with the
GLUT-1 deficiency syndrome after overnight fasting
state, background activity consisted of a small
amount of irregular 7 Hz activity localized in bilat-
eral occipital regions mixed with a large amount of
medium- to high-amplitude 5—6 Hz theta activity
predominant over the bilateral fronto-centro-par-
ietal regions.20 In our studies it is also found that at
the 24th hour of fasting, the peak point of theta
activity shifted from 4 to 6 Hz and the amplitudes of
theta activity increased significantly in all. Previous
findings and our data show that plasma and cerebral
glucose level decreases can cause EEG changes.20
It has been shown that scopolamine may produce
synchronized cortical oscillations and being more
prominent in the eyes-open condition.21 Quantita-
tive EEG studies with scopolamine have revealed
slowing of spontaneous cortical activity, which
manifests itself in decreased alpha22,23 and beta24
power and increased theta22 and delta22,23,25 power
in human. According to our results, scopolamine
causes a decrease in amplitudes of delta, theta and
gamma frequency bands while an increase in ampli-
tudes of alpha and beta frequency bands in compar-
ison with the value of 48 h fasted period. In
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Figure 5 Moving averaged amplitude spectra of scopolamine treatment values comparedwith 48-h values. In EEG of the
animals that fasted for 48 h and were injected with scopolamine, the amplitudes of delta and theta frequencies
decreased significantly in frontal and parietal localizations and the amplitudes of alpha and beta frequencies increased
significantly in parietal and occipital localizations according to 48-h value. The amplitudes of gamma frequency
decreased significantly in all localizations.addition, scopolamine-induced power changes in
the theta bandweremore prominent in the parietal
regions. In naive animals scopolamine causes a
decrease in amplitudes of delta, theta and gamma
frequency bands in all localizationswhile causing an
increase in the amplitudes of alpha frequency band
in parietal localizations. When scopolamine is given
after fasting, it causes an increase in the amplitudes
of beta frequency band differently from the one
observed in naive animals. These results are differ-
ent from the human data. The reason of these
differences may be the different doses of scopola-
mine (0.75 mg/kg versus 3 mg/kg) or species spe-
cific (mouse versus human). Or the reason may be
the time between the recordings and injection of
scopolamine. In human studies, the data were col-
lected 1 h after the injection of scopolamine. But
we recorded the EEG 10 min after the scopolamine
injection. Since it was shown that the effect of
scopolamine is time-depended, the power spectra
differences from the literature may be due torecording time of the EEG. Reduced glucose utiliza-
tion in several cerebral areas with the administra-
tion of scopolamine,26 can also cause those EEG
changes in fasted animals observed in our study.
The incidence of convulsions was 73% after food
intake in animals fasted for 48 h and scopolamine
administrated. When food is not given to the ani-
mals in the same conditions, convulsions do not
occur. A paradoxical low-voltage desynchronization
occurs in EEG after few minutes of eating and sharp
waves are seen. Also pattern of behavioral convul-
sion and EEG properties are changing in the same
direction.
Present findings confirm that food deprivation
seems to be critical in the development of scopo-
lamine-induced convulsions in fasted animals after
food intake. In fasted animals scopolamine treat-
ment decreased the amplitudes of delta and theta
frequencies in frontal and parietal localizations,
while in fed animals scopolamine treatment
decreased the amplitudes of theta frequency in
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Figure 6 Moving averaged amplitude spectra of scopolamine values compared with basal values. In scopolamine
administrated animals’ EEG the amplitudes of theta and gamma frequencies decreased significantly in all localizations
and the amplitudes of alpha and beta frequencies increased significantly in parietal localizations according to basal value.all localizations. In both fasted and fed animals,
scopolamine treatments induced a decrease in the
amplitude of gamma frequency in all localizations.
Also, in fasted animals scopolamine treatment
induced an increase in the amplitudes of alpha
and beta frequencies in parietal and occipital loca-Table 1 Incidence and onset of scopolamine-induced
clonic convulsions in fasted mice after food intakea
Groups Clonic convulsion
n Incidence
(%)
Time of onset (min)
(mean  S.E.)
Control 5 0 —
Scopolamine 11 73b 16.5  9.9
a Mice fasted for 48 h were injected i.p. with saline or
scopolamine (3 mg/kg) treatments and given free access to
food 20 min later, after which they were observed 60 min for
behavioral seizures by an observer who was blind to the
treatment. n: number of animals.
b p < 0.02 significantly different from control group, Fish-
er’s Exact test.lizations while in fed animals scopolamine treat-
ment induced an increase in the amplitudes of alpha
and beta frequencies in parietal localizations.
In food deprivation, the appearance of spiking
activity in the EEG pointed to the increased general
brain excitability. But, food deprivationwas not suffi-
cient alone to trigger the behavioral seizures in these
animals because of an unknown reason. Scopolamine
has an effect on the arrangement of the brain that is
adapted to the hunger. The data presented here
suggest strongly that scopolamine has increased
effects of food deprivation. It could be hypothesized
that,additionofeatingwassufficient to reachthresh-
old for the appearance of behavioral seizures in the
proconvulsive scopolamine-induced brain. Inducing
of convulsions may involve the participation and
interaction of external trigger activation of several
cortical areas or cortex and subcortical structures.27
When neuroanatomy and neurophysiology of eating
are taken into consideration, we can produce some
informed speculation about the particular nature of
these convulsions. It may be speculated that a com-
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Figure 7 EEG recordings and power spectra were shown in scopolamine-induced convulsions in fasted mouse after food
intake. Right, a continuous EEG recording from the right parietal cortical localization leads stages 0—5 and profound
postictal depression. Left, sequential power spectra of the corresponding EEG activity shown on the right (mV2/Hz). y-
axis is mV2 and x-axis is Hz. The time between two vertical solid lines is 1 s in continuous EEG.plex and prolonged behavior such as eating can acti-
vate several regions of cortex and cause provoke
convulsions. Further studies are needed to clarify
the mechanisms of scopolamine-induced convulsions
in fasted animals after food intake.
As a conclusion, the EEG properties and the
behavioral patterns of these convulsions are in
accordance with each other.References
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